Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03037801
NCT03037801
Unknown
N/A

Prospective Randomized Controlled Study of the Use of Intrapulmonary Percussive Ventilation (IPV) for Children With Bronchiolitis Admitted to the Pediatric Intensive Care Unit (PICU) and Are on Non-Invasive Ventilation Support

Soroka University Medical Center1 site in 1 country50 target enrollmentMarch 1, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBronchiolitis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bronchiolitis
Sponsor
Soroka University Medical Center
Enrollment
50
Locations
1
Primary Endpoint
Length of PICU Stay
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Prospective randomized study of patients admitted to the Pediatric Intensive Care Unit suffering from Bronchiolitis and are supported on Non Invasive Positive Pressure Ventilation. The patient population will be divided into two groups, one group will receive conventional treatment and the other group will receive conventional treatment and three times a day of physiotherapy using Intrapulmonary Percussive Ventilation.

Registry
clinicaltrials.gov
Start Date
March 1, 2017
End Date
July 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Bronchiolitis
  • •PICU patients
  • •Non Invasive Pressure Support Ventilation
  • •Age \< 24 months

Exclusion Criteria

  • •Age \> 24 months
  • •Invasive Ventilation
  • •No parental consent

Outcomes

Primary Outcomes

Length of PICU Stay

Time Frame: 10 days

Need for Invasive Ventilation Support

Time Frame: 10 days

Secondary Outcomes

  • Prevention of lung atelectasis(10 days)
  • S/F ratio(Baseline, 15, 30 and 150 minutes after intervention)

Study Sites (1)

Loading locations...

Similar Trials

Terminated
Phase 4
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid EmulsionEssential Fatty Acid Deficiency (EFAD)
NCT02476994Baxter Healthcare Corporation1
Completed
Phase 4
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)Essential Fatty Acid Deficiency (EFAD)
NCT04555044Baxter Healthcare Corporation101
Completed
Phase 3
CATCH - Catheter Infections in ChildrenCatheter-related Infections
NCT01029717Institute of Child Health1,859
Recruiting
Phase 3
Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs.DexmedetomidineMidazolamWithdrawal SymptomsFailure of Extubation
NCT05485519King Abdullah International Medical Research Center430
Terminated
Phase 1
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19DysosmiaAnosmiaCovid19
NCT04964414Amanda Stapleton20